Dosage Form: FOR ANIMAL USE ONLY
Denagard-Medicated Premix
Denagard® 10
(tiamulin)
Medicated Premix
Type A Medicated Article
For manufacture of medicated swine feed only
Active Ingredient:
Tiamulin (as hydrogen fumarate): 10 g/lb
Ingredients:
roughage product, mineral oil
See reverse side for use directions, cautions and warnings.
NADA 139-472, Approved by FDA
Net Weight: 35 lb (15.9 kg)
Denagard® 10
(tiamulin)
Medicated Premix
Type A Medicated Article
For use in animals only.
Store in a dry place.
Indications | Directions | Amount of Denagard 10 Per Ton | Tiamulin in Complete Feed Per Ton | Withdrawal Period (days) |
For treatment of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin | Feed continuously as the sole ration for 14 days | 20 lb | 200 g | 7 |
For control of porcine proliferative enteropathies (ileitis) associated with Lawsonia intracellularis | Feed continuously as the sole ration for not less than 10 days | 3.5 lb | 35 g | 2 |
For control of swine dysentery associated with Brachyspira (formerly Serpulina or Treponema) hyodysenteriae susceptible to Tiamulin | Feed continuously as the sole ration | 3.5 lb | 35 g | 2 |
Warning:
Observe withdrawal time shown in table above. Keep out of reach of children. Avoid contact with skin. Direct contact with skin or mucous membranes may cause irritation.
Caution:
Do not feed undiluted. Do not use in feeds for animals other than swine. The effects of tiamulin on swine reproductive performance, pregnancy and lactation have not been determined.
Contraindications:
Swine being treated with Denagard (tiamulin) should not have access to feeds containing polyether ionophores (e.g., lasalocid, monensin. narasin, salinomycin and semduramicin) as adverse reactions may occur. If signs of toxicity occur, discontinue use.
Restricted Drug (California): Use only as directed.
For more information or to report adverse effects, call 1-800-637-0281.
Denagard® is a registered trademark of Novartis AG.
Product #700
NAH/DEN10-MP/BL/3
Marketed by:
Novartis Animal Health US, Inc.
Greensboro, NC 27408 U.S.A.
Principal Display Panel
Denagard® 10
(tiamulin)
Medicated Premix
Type A Medicated Article
Net Weight: 35 lb (15.9 kg)
NOVARTIS
ANIMAL HEALTH
DENAGARD 10 tiamulin powder | ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
NADA | NADA139472 | 07/17/1987 |
Labeler - Novartis Animal Health US, Inc. (966985624) |
No comments:
Post a Comment